These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27908836)

  • 61. Overexpression of progesterone receptor B increases sensitivity of human colon muscle cells to progesterone.
    Cheng L; Pricolo V; Biancani P; Behar J
    Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G493-502. PubMed ID: 18776045
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Deciphering Specificity Determinants for FR900359-Derived G
    Reher R; Kühl T; Annala S; Benkel T; Kaufmann D; Nubbemeyer B; Odhiambo JP; Heimer P; Bäuml CA; Kehraus S; Crüsemann M; Kostenis E; Tietze D; König GM; Imhof D
    ChemMedChem; 2018 Aug; 13(16):1634-1643. PubMed ID: 29873888
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Heterologous Expression, Biosynthetic Studies, and Ecological Function of the Selective Gq-Signaling Inhibitor FR900359.
    Crüsemann M; Reher R; Schamari I; Brachmann AO; Ohbayashi T; Kuschak M; Malfacini D; Seidinger A; Pinto-Carbó M; Richarz R; Reuter T; Kehraus S; Hallab A; Attwood M; Schiöth HB; Mergaert P; Kikuchi Y; Schäberle TF; Kostenis E; Wenzel D; Müller CE; Piel J; Carlier A; Eberl L; König GM
    Angew Chem Int Ed Engl; 2018 Jan; 57(3):836-840. PubMed ID: 29194875
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Learn from failures and stay hopeful to GPR40, a GPCR target with robust efficacy, for therapy of metabolic disorders.
    Guan HP; Xiong Y
    Front Pharmacol; 2022; 13():1043828. PubMed ID: 36386134
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Regulation of hepatic glucose production by Gq-coupled receptors: potential new targets for treatment of type 2 diabetes.
    Mitchell J
    Endocrinology; 2013 Oct; 154(10):3495-7. PubMed ID: 24058155
    [No Abstract]   [Full Text] [Related]  

  • 66. Applying Molecular Networking for the Detection of Natural Sources and Analogues of the Selective Gq Protein Inhibitor FR900359.
    Reher R; Kuschak M; Heycke N; Annala S; Kehraus S; Dai HF; Müller CE; Kostenis E; König GM; Crüsemann M
    J Nat Prod; 2018 Jul; 81(7):1628-1635. PubMed ID: 29943987
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activation and signaling mechanism revealed by GPR119-G
    Qian Y; Wang J; Yang L; Liu Y; Wang L; Liu W; Lin Y; Yang H; Ma L; Ye S; Wu S; Qiao A
    Nat Commun; 2022 Nov; 13(1):7033. PubMed ID: 36396650
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Thioesterase-mediated side chain transesterification generates potent Gq signaling inhibitor FR900359.
    Hermes C; Richarz R; Wirtz DA; Patt J; Hanke W; Kehraus S; Voß JH; Küppers J; Ohbayashi T; Namasivayam V; Alenfelder J; Inoue A; Mergaert P; Gütschow M; Müller CE; Kostenis E; König GM; Crüsemann M
    Nat Commun; 2021 Jan; 12(1):144. PubMed ID: 33420046
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Respiratory diseases: Gq protein inhibition induces airway relaxation.
    Crunkhorn S
    Nat Rev Drug Discov; 2017 Oct; 16(11):752-753. PubMed ID: 29081526
    [No Abstract]   [Full Text] [Related]  

  • 70. Wound healing: calcium flashes illuminate early events.
    Wood W
    Curr Biol; 2012 Jan; 22(1):R14-6. PubMed ID: 22240471
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Pharmacological properties of a specific Gq/11 inhibitor, YM-254890].
    Kawasaki T; Uemura T; Taniguchi M; Takasaki J
    Nihon Yakurigaku Zasshi; 2006 Jul; 128(1):23-31. PubMed ID: 16940696
    [No Abstract]   [Full Text] [Related]  

  • 72. Cardiomyocyte-specific Gq signalling and arrhythmias: novel insights from DREADD technology.
    Ferrantini C; Coppini R; Sacconi L
    Cardiovasc Res; 2019 May; 115(6):992-994. PubMed ID: 30796427
    [No Abstract]   [Full Text] [Related]  

  • 73. Osteocytes link bone maintenance to blood homeostasis.
    Link DC
    Blood; 2013 Feb; 121(6):867-8. PubMed ID: 23393015
    [No Abstract]   [Full Text] [Related]  

  • 74. Selective Modulation of Gq/Gs pathways by Naphtho Pyrano Pyrimidines as antagonists of the Neuropeptide S Receptor.
    McCoy JG; Marugan JJ; Liu K; Zheng W; Southall N; Huang W; Heilig M; Austin CP
    ACS Chem Neurosci; 2010 Aug; 1(8):559-574. PubMed ID: 21116448
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Protein kinase A-mediated phosphorylation of serine 357 of the mouse prostacyclin receptor regulates its coupling to G
    Lawler OA; Miggin SM; Kinsella BT
    J Biol Chem; 2018 Jul; 293(28):11046. PubMed ID: 30006385
    [No Abstract]   [Full Text] [Related]  

  • 76. Author Correction: Selective optogenetic control of G
    Wagdi A; Malan D; Sathyanarayanan U; Beauchamp JS; Vogt M; Zipf D; Beiert T; Mansuroglu B; Dusend V; Meininghaus M; Schneider L; Kalthof B; Wiegert JS; König GM; Kostenis E; Patejdl R; Sasse P; Bruegmann T
    Nat Commun; 2023 Jan; 14(1):58. PubMed ID: 36599836
    [No Abstract]   [Full Text] [Related]  

  • 77. The Hypothalamic Glucagon-Like Peptide 1 Receptor Is Sufficient but Not Necessary for the Regulation of Energy Balance and Glucose Homeostasis in Mice.
    Burmeister MA; Ayala JE; Smouse H; Landivar-Rocha A; Brown JD; Drucker DJ; Stoffers DA; Sandoval DA; Seeley RJ; Ayala JE
    Diabetes; 2017 Feb; 66(2):372-384. PubMed ID: 27908915
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Mechanistic Study on Nanoparticle-Mediated Glucagon-Like Peptide-1 (GLP-1) Secretion from Enteroendocrine L Cells.
    Beloqui A; Alhouayek M; Carradori D; Vanvarenberg K; Muccioli GG; Cani PD; Préat V
    Mol Pharm; 2016 Dec; 13(12):4222-4230. PubMed ID: 27934480
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An intrinsic agonist mechanism for activation of glucagon-like peptide-1 receptor by its extracellular domain.
    Yin Y; Zhou XE; Hou L; Zhao LH; Liu B; Wang G; Jiang Y; Melcher K; Xu HE
    Cell Discov; 2016; 2():16042. PubMed ID: 27917297
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties.
    Urs NM; Gee SM; Pack TF; McCorvy JD; Evron T; Snyder JC; Yang X; Rodriguiz RM; Borrelli E; Wetsel WC; Jin J; Roth BL; O'Donnell P; Caron MG
    Proc Natl Acad Sci U S A; 2016 Dec; 113(50):E8178-E8186. PubMed ID: 27911814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.